Relay Therapeutics Ownership | Who Owns Relay Therapeutics?
Relay Therapeutics Ownership Summary
Relay Therapeutics is owned by 12.68% institutional investors, 1.51% insiders, and 85.81% retail investors. Sb investment advisers (uk) is the largest institutional shareholder, holding 21.01% of RLAY shares. BB Biotech AG Ord is the top mutual fund, with 4.41% of its assets in Relay Therapeutics shares.
RLAY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Relay Therapeutics | 12.68% | 1.51% | 85.81% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Sb investment advisers (uk) | 27.90M | 21.01% | $181.94M |
| Vanguard group | 15.03M | 10.72% | $61.92M |
| Blackrock funding, inc. /de | 14.67M | 10.46% | $60.46M |
| Blackrock | 10.54M | 7.94% | $68.74M |
| Tang capital management | 8.07M | 5.75% | $33.24M |
| Casdin capital | 9.10M | 5.38% | $23.84M |
| Bellevue group | 7.38M | 5.26% | $30.39M |
| Norges bank | 5.78M | 4.12% | $23.82M |
| Jpmorgan chase | 4.98M | 3.55% | $20.51M |
| State street | 4.25M | 3.20% | $27.70M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Nextech invest | 3.85M | 2.57% | $15.85M |
| Foresite capital management iv | 1.00M | 2.36% | $2.62M |
| Tang capital management | 8.07M | 2.20% | $33.24M |
| Casdin capital | 9.10M | 1.95% | $23.84M |
| Sb investment advisers (uk) | 27.90M | 1.68% | $181.94M |
| Bioimpact capital | 2.30M | 1.03% | $6.02M |
| Kynam capital management, lp | 3.06M | 0.67% | $8.03M |
| Boxer capital | 1.82M | 0.62% | $11.86M |
| Harbourvest partners | 296.40K | 0.60% | $1.22M |
| Bellevue group | 7.38M | 0.59% | $30.39M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 5.78M | 0.00% | 5.78M |
| Tang capital management | 8.07M | 2.20% | 4.50M |
| Blackrock funding, inc. /de | 14.67M | 0.00% | 2.93M |
| Kynam capital management, lp | 3.06M | 0.67% | 2.06M |
| Dimensional fund advisors lp | 2.96M | 0.00% | 1.22M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Braidwell lp | - | - | -3.50M |
| Price t rowe associates inc /md/ | 3.32M | 0.00% | -1.96M |
| Ecor1 capital | 641.43K | 0.10% | -1.86M |
| State street | 4.25M | 0.00% | -1.77M |
| Jacobs levy equity management | - | - | -1.68M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 5.78M | 0.00% | 5.78M | $23.82M |
| Tfg asset management gp | 619.00K | 0.37% | 619.00K | $1.62M |
| Parkman healthcare partners | 500.55K | 0.27% | 500.55K | $2.06M |
| Susquehanna fundamental investments | 346.29K | 0.02% | 346.29K | $1.43M |
| Bnp paribas arbitrage, snc | 239.67K | 0.00% | 239.67K | $987.43K |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Capital performance advisors llp | -11.00 |
| Parallel advisors | -14.00 |
| Nelson, van denburg & campbell wealth management group | -18.00 |
| First command advisory services | -25.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 13 | -93.60% | 21,465,711 | -86.91% | 12 | 0.09% | 8 | -93.89% | 2 | -94.44% |
| Dec 31, 2024 | 192 | -3.52% | 130,207,976 | -17.33% | 92 | 0.74% | 123 | 4.24% | 35 | -22.22% |
| Sep 30, 2024 | 198 | 11.24% | 157,463,305 | 24.21% | 112 | 1.23% | 118 | 20.41% | 45 | -6.25% |
| Jun 30, 2024 | 178 | -4.30% | 126,768,728 | -1.54% | 95 | 0.99% | 98 | -3.92% | 48 | - |
| Mar 31, 2024 | 186 | 5.68% | 128,755,897 | 1.37% | 98 | 0.92% | 102 | 18.60% | 48 | -17.24% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 7.38M | 4.41% | - |
| Vanguard Total Stock Mkt Idx Inv | 5.29M | 3.10% | 295.64K |
| Vanguard US Total Market Shares ETF | 4.89M | 2.88% | 904.00K |
| iShares Russell 2000 ETF | 3.19M | 1.86% | 1.56K |
| Eventide Healthcare & Life Sciences I | 2.68M | 1.58% | - |
| SPDR® S&P Biotech ETF | 2.31M | 1.35% | 2.99K |
| JPMorgan Small Cap Growth A | 2.19M | 1.28% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.03M | 1.19% | 4.97K |
| Vanguard Small Cap Index | 2.01M | 1.18% | 2.34K |
| Belfius Equities Cure C Cap | 1.73M | 1.02% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 30, 2025 | Rahmer Peter | See remarks | Sell | $32.22K |
| Apr 28, 2025 | Rahmer Peter | See remarks | Sell | $4.32K |
| Apr 28, 2025 | Catinazzo Thomas | Chief Financial Officer | Sell | $3.11K |
| Apr 28, 2025 | Catinazzo Thomas | Chief Financial Officer | Sell | $5.42K |
| Apr 29, 2025 | Catinazzo Thomas | Chief Financial Officer | Sell | $11.49K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 12 |
| 2025 Q1 | - | 25 |
| 2024 Q4 | - | 12 |
| 2024 Q3 | - | 15 |
| 2024 Q2 | - | 12 |
RLAY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools